Team

ho

Patrick Ho, J.D.

Vice President, Chief Business Officer

Patrick works closely with President Mitch Kronenberg and the Board of Directors to advance the mission of La Jolla Institute. In concert with executive management, he helps develop and implement strategic organizational goals and programs.

Technology Development was formed in 2007 to manage intellectual property, and it has since evolved into a significant resource for translating basic research discoveries and supporting institutional growth. Serving as the senior leader for commercialization activities, Patrick is responsible for generating, implementing and driving both innovations and new business opportunities with both industry and the entrepreneur/investment community. He actively contributes to the inventive process and he engages with faculty to help translate ideas and discoveries into tangible technologies.

He has broad and comprehensive scientific and intellectual property expertise from working in the biotech industry for over 20 years. Patrick holds a Juris Doctor and received his undergraduate biology degree from University of San Diego.

Business Development

kolla

Ravi Kolla, Ph.D.

Director, Technology Development

Ravi received his Ph.D. in Immunology from the University of California, San Diego (UCSD). As part of his doctoral research, he studied B cell activation and signal transduction and developed methods to use the innate immune system to bolster the antibody response against infectious agents. He continued his postdoctoral studies at the UCSD Medical School in the Division of Rheumatology, where he conducted research studying antibodies and B cells with anti-inflammatory properties in rheumatoid arthritis and systemic lupus erythematosus.

Prior to joining Technology Development in 2015, Ravi served as a Senior Project Manager within the Division of Vaccine Discovery at the La Jolla Institute where he oversaw numerous, highly-matrix programs that focused on utilizing the T cell immune response to protect against infectious viruses, bacteria, and allergens. Prior to this role, Ravi was employed at the Novartis Institute for Biomedical Research as a Project Manager in Drug Discovery managing numerous cross-functional and geographically diverse small molecule and biologic drug development programs across immunology, oncology, infectious disease, and muscular-skeletal disease. Throughout his career, he has gained significant expertise in human immunology and disease.

In Technology Development, he provides scientific expertise to support development of new business initiatives and faculty research projects.

ColleenBarefield

Colleen Barefield, PhD

Business Development Manager

Colleen serves as a liaison between Business Development and IP and Contracts in Technology Development, particularly supporting commercial collaborations. Before joining La Jolla Institute, Colleen trained in diverse fields of biomedical research and therapeutic development, and her expertise extends to genetics and molecular biology in the fields of allergy, neurological disease, metabolic disease, and oncology. Her experience in industry encompasses high-throughput assay development and screening, and pre-clinical drug development.

After receiving her B.A. in Biology from Grinnell College, she spent 2 years in a pediatric epidemiology research laboratory at Washington University School of Medicine. Colleen obtained her Ph.D. from University of California San Diego and performed her doctoral research at the Salk Institute for Biological Studies where she studied chromosome end maintenance in the context of cancer and premature aging disorders. She then performed post-doctoral studies at the California Institute for Biomedical Research, a non-profit organization focused on translational research.

Intellectual Property & Contracts

hing

Margaret (Ng Thow) Hing, J.D.

Director, Technology Development

Margaret (Ng Thow) Hing oversees all aspects of La Jolla Institute’s patent portfolio and technology agreements, and supports business development functions. In addition, she is active in drafting and prosecuting patent applications to issuance. Margaret works with scientific personnel on a daily basis to support their research activities by facilitating access to research tools and technologies, and ensuring intellectual property protection of research discoveries.

Prior to joining the Institute, Margaret was an attorney with Smart & Biggar, Fetherstonhaugh, a leading intellectual property and technology law firm. She advised clients on patent prosecution matters with a focus in the area of biotechnology. Margaret obtained a Master of Science in Molecular & Medical Genetics and J.D. from the University of Toronto, Canada.

ErinRandolph

Erin Randolph

Contract Specialist

Erin Randolph, as the Contract Specialist within Technology Development, is responsible for drafting and negotiating technology transfer agreements and manages the daily administrative operations of Technology Development. She has a background in contract review, communications, and operations.

Before joining LJI, Erin was an Executive Assistant at a major real estate firm and she previously handled marketing for the Bellagio (Las Vegas). Erin received her Bachelor of Business Administration in Management at Western Michigan University.